Table 1.
Baseline Demographic and Clinical Characteristics of Patients in the Entire Study Sample and in the 2 Subgroups of Patients
| Variable | All Patients (n=315) |
Statin Group (n=35) |
Nonstatin Group (n=280) |
P* |
|---|---|---|---|---|
| Age, y | 61±12 | 60±9 | 61±13 | 0.66 |
| Female, n (%) | 224 (71) | 23 (66) | 201 (72) | 0.64 |
| Atrial fibrillation, n (%) | 119 (38) | 9 (28) | 110 (39) | 0.17 |
| Hypercholesterolemia, n (%) | 70 (22) | 31 (89) | 39 (14) | <0.001 |
| Hypertension, n (%) | 94 (30) | 17 (49) | 77 (28) | 0.018 |
| Diabetes mellitus, n (%) | 48 (15) | 5 (14) | 43 (15) | 0.93 |
| CAD, n (%) | 139 (44) | 25 (71) | 114 (41) | 0.001 |
| Follow-up, y | 6.1±4.0 | 7.1±4.2 | 5.9±4 | 0.097 |
*
P value for comparisons between statin group and nonstatin group.